No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Human Body May Reject Plastic-Based Medical Devices

It is hard to believe that the FDA would allow Physiomesh to come to market given the problems Ethicon Inc., had with their Transvaginal mesh, a similar, polypropylene-based medical device

Thursday, July 12, 2018 - The essence of Ethicon Physiomesh design is that the material from which it is made is interwoven with polypropylene fiber, a material that appears to be behind the hoards of complaints made by Physiomesh patients requiring revision surgery to remove the medical device and support their hernia. According to Google, polypropylene is "a synthetic resin which is a polymer of propylene, used chiefly for films, fibers, or molding materials." www.plasticsmadepossible.com calls polypropylene, "a multifunctional multi-tasker in your kitchen (utensils), your closet (athletic apparel), your family room (area rugs), your car (batteries) . . . in fact, polypropylene is found in just about every market sector that uses plastics. Sort of like a superhero of plastics." The authoritative plastics website adds that the features of polypropylene include " a high melting point, so it's used for many microwave containers; It doesn't react with water, detergents, acids, or bases, so it won't break down easily; It's resistant to cracking and stress, even when flexed, so it's used in lots of hinges." Nowhere is it apparent that polypropylene, a petroleum-based plastic material whose primary purpose is in single-use plastic bags, could ever be placed permanently within the human body without causing unforeseen adverse events to occur. The purpose of the Physiomesh fibers is to create inflammation in the underlying tissue and use the body's reaction in creating scar tissue to hold the device in place.

After several years of implanting hernia patients with Ethicon hernia mesh containing polypropylene, the complaints from patients became overwhelming. Physimesh patient requiring revision surgery consulted with Physiomesh attorneys and allege the device is the cause of hernia recurrences, infection, swelling, abscesses, intestinal blockages, and of course excruciating and debilitating pain. In response to unpublished data from two respected independent hernia registries pointing to patients that had laparoscopic ventral hernia surgery using Physiomesh having a higher than average rate of revision surgery, the Ethicon Medical Safety Team recommended to the company that they voluntarily withdraw Physiomesh Composite Hernia Repair Device from the market worldwide and permanently an unusual move, to say the least from a company earning hundreds of millions of dollars selling the medical device. Polypropylene component of Physiomesh can break down causing the device to painfully pull away from the site of a hernia where it is free to migrate with the abdomen. Patients have complained of painful and dangerous blockages in the lower bowels due to Physiomesh disintegrating and puncturing the intestines.

Years earlier another polypropylene-based mesh product, the Ethicon transvaginal mesh, had similar problems that resulted in billions of dollars in legal costs to Ethicon and their subsidiary Johnson & Johnson. It is a wonder how Physiomesh made it through the FDA's 501 (k) fast-track program and was rushed to market without first requiring clinical testing to determine whether or not polypropylene would be rejected by the body's immune system as happened with the transvaginal mesh. It is not a wonder that thousands of Ethicon Physiomesh lawsuits are now being filed.

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.